News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
86,534 Results
Type
Article (2688)
Company Profile (2)
Press Release (83844)
Section
Business (25354)
Career Advice (514)
Deals (5785)
Drug Delivery (4)
Drug Development (13093)
Employer Resources (27)
FDA (1744)
Job Trends (1761)
News (45661)
Policy (3764)
Tag
2024 Biotech Bay Standard (1)
Academia (221)
Allergies (15)
Alliances (4652)
ALS (16)
Alzheimer's disease (314)
Antibody-drug conjugate (ADC) (10)
Approvals (1757)
Artificial intelligence (35)
Autoimmune disease (6)
Bankruptcy (70)
Best Places to Work (1619)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (4)
Bladder cancer (27)
Brain cancer (5)
Breast cancer (26)
Cancer (385)
Cardiovascular disease (17)
Career advice (412)
Career pathing (3)
CAR-T (20)
Cell therapy (91)
Cervical cancer (4)
Clinical research (11061)
Collaboration (114)
Compensation (33)
Complete response letters (1)
COVID-19 (266)
CRISPR (3)
C-suite (36)
Cystic fibrosis (9)
Data (543)
Decentralized trials (1)
Denatured (3)
Depression (5)
Diabetes (44)
Diagnostics (906)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (8)
Drug discovery (15)
Drug pricing (4)
Duchenne muscular dystrophy (8)
Earnings (14116)
Editorial (6)
Employer branding (4)
Employer resources (28)
Events (15268)
Executive appointments (116)
FDA (1965)
Featured Employer (1)
Friedreich's ataxia (1)
Frontotemporal dementia (1)
Funding (92)
Gene editing (11)
Generative AI (1)
Gene therapy (41)
GLP-1 (88)
Government (386)
Guidances (11)
Healthcare (2500)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (290)
Inflammatory bowel disease (22)
Inflation Reduction Act (2)
Influenza (12)
Intellectual property (29)
Interviews (122)
IPO (3679)
IRA (1)
Job creations (220)
Job search strategy (338)
Kidney cancer (3)
Labor market (2)
Layoffs (18)
Leadership (6)
Legal (718)
Liver cancer (9)
Lung cancer (59)
Lymphoma (22)
Management (11)
Manufacturing (39)
MASH (25)
Medical device (1925)
Medtech (1925)
Mergers & acquisitions (2284)
Metabolic disorders (114)
Multiple sclerosis (19)
NASH (7)
Neurodegenerative disease (13)
Neuropsychiatric disorders (3)
Neuroscience (418)
NextGen: Class of 2025 (656)
Non-profit (388)
Northern California (621)
Obesity (43)
Opinion (24)
Ovarian cancer (13)
Pain (18)
Pancreatic cancer (32)
Parkinson's disease (32)
Partnered (1)
Patents (72)
Patient recruitment (18)
Peanut (11)
People (6723)
Pharmaceutical (1)
Pharmacy benefit managers (1)
Phase I (3615)
Phase II (5118)
Phase III (3388)
Pipeline (358)
Podcasts (16)
Policy (22)
Postmarket research (209)
Preclinical (1388)
Press Release (3)
Prostate cancer (20)
Psychedelics (2)
Radiopharmaceuticals (44)
Rare diseases (70)
Real estate (373)
Recruiting (11)
Regulatory (2951)
Reports (3)
Research institute (181)
Resumes & cover letters (83)
Rett syndrome (3)
RSV (6)
Schizophrenia (15)
Series A (10)
Series B (4)
Sickle cell disease (9)
Southern California (558)
Spinal muscular atrophy (30)
Sponsored (1)
Startups (161)
Supply chain (9)
Tariffs (5)
The Weekly (12)
United States (5001)
Vaccines (76)
Venture capitalists (3)
Weight loss (16)
Women's health (1)
Worklife (3)
Date
Today (13)
Last 7 days (152)
Last 30 days (656)
Last 365 days (7403)
2025 (1837)
2024 (7791)
2023 (9107)
2022 (9211)
2021 (9651)
2020 (8809)
2019 (5895)
2018 (4109)
2017 (4345)
2016 (3313)
2015 (4408)
2014 (2694)
2013 (1860)
2012 (2016)
2011 (2114)
2010 (1844)
Location
Africa (108)
Alabama (11)
Arizona (15)
Arkansas (1)
Asia (4554)
Australia (685)
California (1426)
Canada (373)
China (53)
Colorado (46)
Connecticut (65)
Delaware (16)
Europe (8874)
Florida (160)
Georgia (48)
Idaho (1)
Illinois (90)
India (3)
Indiana (49)
Japan (20)
Kansas (42)
Kentucky (2)
Maine (5)
Maryland (151)
Massachusetts (843)
Michigan (41)
Minnesota (62)
Missouri (3)
Montana (1)
Nebraska (5)
Nevada (9)
New Hampshire (19)
New Jersey (499)
New York (537)
North Carolina (108)
Northern California (621)
Ohio (13)
Oregon (2)
Pennsylvania (394)
Rhode Island (7)
South America (170)
South Carolina (2)
Southern California (558)
Tennessee (27)
Texas (219)
Utah (10)
Virginia (41)
Washington D.C. (15)
Washington State (121)
Wisconsin (2)
86,534 Results for "autism speaks".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
LinusBio and The BRAIN Foundation Partner to Advance Biomarker-Supported Autism Diagnosis and Early Intervention
April 2, 2025
·
4 min read
Press Releases
Groundbreaking Autism Biomarker: LinusBio Launches ClearStrand-ASD to aid Health Care Providers in Ruling Out Autism Using a Single Strand of Hair
February 6, 2025
·
4 min read
Press Releases
Oryzon Announces Publication of Study on Phelan-McDermid Syndrome (PMS) Patients, a Form of Autism, Paving the Way for a Novel Personalized Medicine Approach with Vafidemstat
March 5, 2025
·
9 min read
Press Releases
Autism Spectrum Disorder Markets Expected to Exhibit a CAGR Of 5.84% During 2025-2035, impelled by Innovative Treatments
February 13, 2025
·
10 min read
Drug Development
As Autism Cases Rise, Biopharma Springs Into Action
Several companies—including Roche, Curemark and Yamo Pharmaceuticals—are running clinical trials of treatments that aim to offset the myriad challenges of autism.
April 25, 2024
·
6 min read
·
Tyler Patchen
Drug Development
STALICLA publishes pioneering phase 1b data on precision treatment for autism spectrum disorder in Biomedicines
STALICLA SA announced the publication of a landmark phase 1b study with STP1, a novel combination therapy tailored for the treatment of a clinically and biologically defined subgroup of patients with autism spectrum disorder, named ASD Phenotype 1.
June 27, 2024
·
3 min read
Press Releases
PaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other Conditions
January 14, 2025
·
4 min read
Biotech Beach
Clinical Study Highlights Improvements to Gut Microbiome and Autism Spectrum Disorder Symptoms with Use of Custom Probiotics
Researchers with Sun Genomics and Arizona State University have discovered that probiotic supplementation may improve symptoms in people with autism spectrum disorder.
May 7, 2024
·
5 min read
FDA
FDA Layoffs Continue as Former Commissioner Robert Califf Speaks Out
The latest cuts, which are part of a larger reduction of 10,000 at the Department of Health and Human Services, were reportedly underway Tuesday, with CDER Office of New Drugs Director Peter Stein added to the list of casualties.
April 1, 2025
·
2 min read
·
Heather McKenzie
SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial
SciSparc Ltd. today announced that it has successfully dosed the first patient in its SCI-210 clinical trial at the Soroka Medical Center for pediatric patients who have Autism Spectrum Disorder (“ASD”).
March 14, 2024
·
3 min read
1 of 8,654
Next
